RGC - CIK 0001829667
Regencell Bioscience Holdings Ltd trades as RGC and has a market capitalization of $10.11 B, making it the #936 largest US-listed company by market value. This page tracks Regencell Bioscience Holdings Ltd through 82 SEC filings, with financial statements and metrics updated as new reports are filed.
| Filing | Type | Filed |
|---|---|---|
| 6-K | - | 2026-05-22 |
| Prospectus supplement | 424B5 | 2026-05-19 |
| 6-K | - | 2026-05-19 |
| 6-K | - | 2026-05-19 |
| 6-K | - | 2026-05-08 |
| 6-K | - | 2026-04-17 |
| 6-K | - | 2026-03-30 |
| 6-K | - | 2026-03-30 |
The largest companies sharing Regencell Bioscience Holdings Ltd's SEC industry classification (medicinal chemicals & botanical products).
Regencell Bioscience Holdings Ltd (RGC) has a market capitalization of $10.11 B as of 2026-06-10, ranking #936 among US-listed companies.
In its latest fiscal year Regencell Bioscience Holdings Ltd reported a net loss of $3.58M.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
Dig into the full income statement, balance sheet, and cash flow statement with annual and quarterly views.